LipoScience.

PositionTriangle - Brief Article

RALEIGH -- LipoScience, inventor of a test that measures cholesterol to assess risk of heart disease, has asked the U.S. Securities and Exchange Commission for permission to sell as much as $100 million in stock in an initial public offering. The...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT